Director/PDMR Shareholding

RNS Number : 8446L

Hutchison China Meditech Limited

19 January 2009

 



Hutchison China MediTech Limited ('Chi-Med') 

(AIM: HCM)

Director's Shareholding

London: Monday, 19 January 2009: Chi-Med was informed on 16 January 2009 that Mr Michael Howell, Independent Non-executive Director of Chi-Med, purchased 100,000 ordinary shares of US$1.00 each in Chi-Med (the 'Shares') at a price of 42.5p each on 15 January 2009.

Following this purchase, Mr Howell is beneficially interested in 143,000 Shares, representing approximately 0.3% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle    David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

RDSGIGDBXDBGGCC